Biosafety guidance for diagnostic laboratories handling specimens from individuals with possible, probable or confirmed infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Middle East Respiratory Syndrome Coronavirus or Avian Influenza A : V3.0, 14/02/2020
File Type:
PDFItem Type:
otherDate:
2020-02-14Access:
openAccessCitation:
Health Protection Surveillance Centre, 'Biosafety guidance for diagnostic laboratories handling specimens from individuals with possible, probable or confirmed infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Middle East Respiratory Syndrome Coronavirus or Avian Influenza A : V3.0, 14/02/2020', [other], Health Protection Surveillance Centre, 2020-02-14Description:
This guidance has been reviewed in the context of the emergence of with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the area of Wuhan, Hubei province in China. As yet, we do not fully understand the pathogenic potential and transmission dynamics of SARS-CoV-2, for further information refer to the hpsc website.Corporate name:
Health Protection Surveillance CentrePublisher:
Health Protection Surveillance CentreType of material:
otherCollections
Availability:
Full text availableKeywords:
Covid-19, Coronavirus, Laboratory guidanceMetadata
Show full item recordLicences: